Catalyst
Slingshot members are tracking this event:
Genocea(GNCA) presents new Phase 1/2 data of GEN-009 Vaccine Immune Responses to ATLAS-selected Neoantigens in Cancer Patients
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
GNCA |
|
|
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jun 03, 2019
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Gen-009, Neoantigens, Cancer